Economy · India
US FDA Clears Glenmark's Goa Pharma Facility
Glenmark Pharmaceuticals' formulations manufacturing facility in Goa has received clearance from the US Food and Drug Administration (FDA). The US health regulator conducted an inspection at the facility from June 22 to June 30. Glenmark announced on September 23 that the facility received a Voluntary Action Indicated (VAI) status, meaning no immediate regulatory action is required. The company received an Establishment Inspection Report (EIR) for the facility.
How outlets across the spectrum covered it
L 0 C 3 R 0
- Centre (3): Business Standard, Business Today, The Hindu BusinessLine